Trilogy Capital Inc. Zimmer Biomet Holdings, Inc. Transaction History

Trilogy Capital Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 11, 2019	SELL	$108.87 - $125.09 $194,550 - $223,535	-1,787 Closed	0 $0
Q1 2019 Apr 17, 2019	SELL	$97.5 - $125.79 $57,817 - $74,593	-593 Reduced 24.92%	1,787 $228,000
Q4 2018 Jan 15, 2019	SELL	$94.4 - $126.76 $44,368 - $59,577	-470 Reduced 16.49%	2,380 $247,000
Q3 2018 Oct 31, 2018	SELL	$108.41 - $127.64 $51,711 - $60,884	-477 Reduced 14.34%	2,850 $375,000
Q2 2018 Aug 20, 2018	SELL	$102.12 - $114.04 $48,813 - $54,511	-478 Reduced 12.56%	3,327 $371,000
Q1 2018 May 24, 2018	BUY	$104.31 - $124.46 $396,899 - $473,570	3,805 New	3,805 $415,000

1,079

178M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $21.9B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Trilogy Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Trilogy Capital Inc. with notifications on news.